Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole: A Dose Escalation Study of Efficacy and Tolerability

NCT03038308 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT03038308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03038308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole: A Dose Escalation Study of Efficacy and Tolerability
Lead sponsor
Columbia University
Phase
Phase 1/2
Overall status
Completed
Start date
September 16, 2016
Completion date
November 5, 2020
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperprolactinemia, prolactinoma